COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804

Article view: 783

Article download: 213

IP Indian Journal of Immunology and Respiratory Medicine


Pseudomyxoma pleurii- A case report with clinicopathology and management of a rare Clinical presentation


Full Text PDF Share on Facebook Share on Twitter


Author Details : Devender Singh, Shegu Gilbert, Sudhakar Natrajan, Paulvannan Subramanian, Sadayandi Kandasamy

Volume : 1, Issue : 2, Year : 2016

Article Page : 40-42


Suggest article by email

Abstract

Pseudomyxoma pleurii is an unusual clinical syndrome caused by trans-diaphragmatic spread of pseudomyxoma peritonei due to mucinous adenocarcinoma of the appendix. The disease is highly lethal. We present one such patient who had underwent renal transplant and on immunosuppression therapy developed pseudomyxoma pleurii. Cytoreduction surgery and hyperthermic chemo perfusion were done which is the standard treatment for these patients which has an impact on the overall survival and disease free survival.

Keywords
: Pseudomyxoma peritonei; Adenocarcinoma, Mucinous; Lung neoplasms; Thoracic surgery; Pleural neoplasms

How to cite : Singh D, Gilbert S, Natrajan S, Subramanian P, Kandasamy S, Pseudomyxoma pleurii- A case report with clinicopathology and management of a rare Clinical presentation. IP Indian J Immunol Respir Med 2016;1(2):40-42

Copyright © 2016 by author(s) and IP Indian J Immunol Respir Med. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)